Inclusion Criteria:  Confirmed diagnosis of unresectable advanced/metastatic solid tumor Life expectancy of at least 3 months Adequate bone marrow and organ function  Exclusion Criteria:  Ongoing medical condition or need for treatment with medication that may affect the PK of study treatments during Part 1 Immunocompromising conditions Impaired heart function Active or prior documented autoimmune disease